BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 35671329)

  • 1. Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study.
    Ajabnoor AM; Zghebi SS; Parisi R; Ashcroft DM; Rutter MK; Doran T; Carr MJ; Mamas MA; Kontopantelis E
    PLoS Med; 2022 Jun; 19(6):e1004003. PubMed ID: 35671329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
    Rahman AA; Michaud J; Dell'Aniello S; Moodie EEM; Brophy JM; Durand M; Guertin JR; Boivin JF; Renoux C
    Neurology; 2023 Mar; 100(12):e1309-e1320. PubMed ID: 36581462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study.
    Mitchell A; Snowball J; Welsh TJ; Watson MC; McGrogan A
    BMC Med; 2021 Aug; 19(1):189. PubMed ID: 34461899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frailty, Cognitive Impairment, and Anticoagulation Among Older Adults with Nonvalvular Atrial Fibrillation.
    Mailhot T; McManus DD; Waring ME; Lessard D; Goldberg R; Bamgbade BA; Saczynski JS
    J Am Geriatr Soc; 2020 Dec; 68(12):2778-2786. PubMed ID: 32780497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time Trends in Patient Characteristics, Anticoagulation Treatment, and Prognosis of Incident Nonvalvular Atrial Fibrillation in the Netherlands.
    Chen Q; Toorop MMA; Tops LF; Lijfering WM; Cannegieter SC
    JAMA Netw Open; 2023 Apr; 6(4):e239973. PubMed ID: 37097630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009-2019.
    Ajabnoor AM; Parisi R; Zghebi SS; Ashcroft DM; Faivre-Finn C; Morris C; Mamas MA; Kontopantelis E
    Cancer; 2024 Apr; 130(8):1316-1329. PubMed ID: 38115738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with non-prescription of oral anticoagulant treatment in non-valvular atrial fibrillation patients with dementia: a CPRD-HES study.
    Besford M; Graham S; Sammon C; Mehmud F; Allan V; Alikhan R; Ramagopalan S
    Age Ageing; 2020 Jul; 49(4):679-682. PubMed ID: 32242616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.
    Mitchell A; Welsh TJ; Watson MC; Snowball J; McGrogan A
    BMJ Open; 2019 Dec; 9(12):e032646. PubMed ID: 31843842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to prescribing oral anticoagulants to inpatients aged 80 years and older with nonvalvular atrial fibrillation: a cross-sectional study.
    Xia X; Wang L; Lin T; Yue J; Yang Z; Mi C; Liao Z; Chen Y; Ge N; Wu C
    BMC Geriatr; 2022 Mar; 22(1):263. PubMed ID: 35354397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation.
    Admassie E; Chalmers L; Bereznicki LR
    Am J Cardiol; 2017 Oct; 120(7):1133-1138. PubMed ID: 28781025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
    Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
    JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease.
    Arnson Y; Hoshen M; Berliner-Sendrey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
    Cardiology; 2020; 145(3):178-186. PubMed ID: 31955174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study.
    Jung H; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Thromb Haemost; 2019 Feb; 119(2):285-293. PubMed ID: 30602200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain.
    Polo García J; Vargas Ortega D; Formiga F; Unzueta I; Fernández de Cabo S; Chaves J
    Semergen; 2019 Sep; 45(6):396-405. PubMed ID: 30573367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis.
    Harrison SL; Buckley BJR; Ritchie LA; Proietti R; Underhill P; Lane DA; Lip GYH
    J Am Geriatr Soc; 2022 Aug; 70(8):2386-2392. PubMed ID: 35587227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
    Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
    Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex.
    Pilcher SM; Alamneh EA; Chalmers L; Bereznicki LR
    Ann Pharmacother; 2020 Sep; 54(9):837-845. PubMed ID: 32019321
    [No Abstract]   [Full Text] [Related]  

  • 18. Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation.
    Guo JS; He M; Gabriel N; Magnani JW; Kimmel SE; Gellad WF; Hernandez I
    J Manag Care Spec Pharm; 2022 Dec; 28(12):1400-1409. PubMed ID: 36427343
    [No Abstract]   [Full Text] [Related]  

  • 19. Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation.
    Durham TA; Hassmiller Lich K; Viera AJ; Fine JP; Mukherjee J; Weinberger M; Dusetzina SB
    Am J Cardiol; 2017 Nov; 120(10):1820-1829. PubMed ID: 28867127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Frailty and Associations with Oral Anticoagulant Prescribing in Atrial Fibrillation.
    Sanghai SR; Liu W; Wang W; Rongali S; Orkaby AR; Saczynski JS; Rose AJ; Kapoor A; Li W; Yu H; McManus DD
    J Gen Intern Med; 2022 Mar; 37(4):730-736. PubMed ID: 33948795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.